top of page
Jellyfish in Aquarium_edited.jpg

Stanislav Skakun

 Co-founder and CEO, Biodata

Stanislav Skakun is the CEO and founder of Biodata, a platform specializing in medical and biological data storage and bioinformatics. Simultaneously, he is a self-quantification enthusiast. Since 2014, Skakun has been conducting self-measurement experiments, assessing 300-400 biochemical parameters in his body each month. Consequently, this experiment has collected data from over 15,000 medical measurements, making it one of the largest experiments of its kind. Skakun believes that the key to success lies in foundational health—sufficient nutrition, balanced hormones, and a healthy nervous system.

 Zhou Songyang

 Director, Anti-Aging Center, Sun Yat-sen University

Prof. Zhou Songyang is a Doctoral Supervisor and the Director of the Anti-Aging Center at Sun Yat-sen University. He has published over 150 papers in internationally renowned journals such as Nature, Science, Cell, PNAS, Nature Cell Biology, NSMB, Molecular Cell, with a total citation count exceeding 20000. He has received several honors, including the Annual Best Paper Award from the Scientist, the 30-Year Best 30 Articles Award from Cell journal, Irvington Institute Postdoctoral Fellowship, Ellison New Scholar, American Cancer Society Scholar, and Leukemia and Lymphoma Society Scholar.

John Speakman_edited.jpg

John Speakman

Principal Investigator, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences

John Speakman is a Professor at the Shenzhen Institutes of Advanced Technology in Shenzhen, China and also at the University of Aberdeen in Scotland, UK. He has been working on energy balance and obesity for more than 40 years. During that time he published over 600 scientific papers including 11 in Nature/Science, and was featured twice on the cover of Nature. He is a foreign member of the US National Academy of Sciences, an academician of the Chinese National Academy of Sciences and a Fellow of the UK Royal Society. He was awarded the US Obesity Society TOPS award and Osborne-Mendel prize by the American Society of Nutrition.

Yu Sun

Researcher, Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences

Dr. Sun Yu is a Researcher at Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences and also the Director of Institute of Aging Medicine, Binzhou Medical University. He graduated from Dalhousie University of Canada with a Ph.D. and received postdoctoral training at the University of British Columbia (UBC) and Fred Hutchinson Cancer Research Center (FHCRC). His research primarily focuses on the pathological correlation between cellular senescence, organ degeneration and age-related diseases. He excels at development of frontline antiaging drugs and their potential application in future clinics. Professor Sun has been honored with the Special Prize from the US NCI Northwest Prostate Cancer SPORE, the Best Alumni Lecture Award from the University of British Columbia in Canada, and the Top Discovery Award from the University of Washington in the US, a series of international laurels.

Yu Sun
Dario valenzan3.png

Dario Riccardo Valenzano

Senior Group Leader, the Leibniz Institute on Aging

Dr. Dario Riccardo Valenzano is full professor at the Friedrich Schiller University in Jena (Germany) and Senior Group Leader at the Leibniz Institute on Aging (Fritz-Lipmann Institute), where he coordinates the research focus Microbiome and Aging. Valenzano research team apply an evolutionary and ecological perspective to the study of host-microbiome interactions in the context of health, disease and aging and focus on studies the genomic basis of short/long lifespan across species.

Yadav Vijay

Assistant Professor, Columbia University

Dr. Vijay lead Systems Biology of Aging Laboratory, which aims to identify novel functional connections between organs and to unravel factors that underlie human metabolism and its disorders. The expertise of his lab is in the development of a variety of technologies including mouse genetic (CRISPR/Cas, homologous recombination in embryonic stem cells, iPS cells), genomic (Nucleic acid sequencing), and proteomic (MS/NMR/HPLC). The ultimate aim is to identify novel therapeutic targets for genetic and metabolic disorders to manage these diseases in humans.

Yadav Vijay_edited.png
Gelin Wang_edited.jpg

Gelin Wang

Researcher and doctoral supervisor, School of Pharmacy, Tsinghua University

Dr. Wang did her postdoctoral research at the University of Texas Southwestern Medical Center and was later promoted to lecturer and Grand Program Co-Director at the National Center for Health. In 2015, she joined Calico, a life sciences company founded by Google, to research and develop a class of drugs against degenerative neurological diseases. After joining the School of Pharmacy of Tsinghua University, her main research direction is to understand the biological process of aging and the screening and development of anti-aging drugs. Up to now, she has published more than 10 SCI papers in international authoritative journals such as Cell, Nature, Nature Chemical Biology, Genes & Dev., PNAS, etc.

Liangjing Wang

Professor, Zhejiang University

Director, Research Center of Prevention and Treatment of Senescent Disease, School of Medicine, Zhejiang University

Prof. Wang has been the vice president of the Second Affiliated Hospital of Zhejiang University School of Medicine since 2021. He specializes in the treatment of gastric precancerous lesions (dysplasia), early gastric cancer, gastric stromal tumor, as well as atrophic gastritis intervention block, cirrhosis of the esophagus and gastric varices and other diseases. He is mainly engaged in research on pathogenesis and intervention blocking of gastrointestinal precancerous lesions and tumor epigenetics.

Liangjing Wang
Zhao Wang

Zhao Wang

Director, the Institute of Pharmacology, Tsinghua University

Pioneer of the undergraduate course "Biology of Aging" in Chinese universities

Professor Wang is a member of the Scientific Committee of Aging and Anti-aging of the Chinese Gerontological Society, a standing member of Chinese Association of Traditional Chinese Medicine Branch, and a reviewer of the National Natural Science Foundation of China. Besides, he serves as member of editorial board of Journal of Pharmacological Sciences and Food Science and Human Wellness. Professor Wang’s research interests include molecular and cellular pharmacology and toxicology, aging mechanisms and drug intervention, and the research and development of natural medicines and functional health products

Meihong Xu

Assistant Professor, Peking Universityy

 Dr. Meihong Xu is the Assistant Professor, Doctoral Supervisor of Peking University (PhD). She has been committed to nitrogen source nutrition, healthy aging, and food toxicology research. She presided over 9 projects of National, and Beijing Natural Science Foundation and domestic and foreign cooperative research funds, as well as participated in a number of cooperative research fund projects. She has published more than 50 academic papers as the first or responsible author. She presented as chief editor of "Nucleotide Nutrition (first edition, second edition)", deputy editor of "walnut peptide nutrition", "ginseng peptide nutrition", "Oat nutrition" and "fish collagen peptide nutrition", participated in the editing of "peptide clinical nutrition" and "Nutritional support for surgical diseases" and other books. Developed and taught a series of courses such as "Nutrition and Aging" and "Peptide Nutrition". She is also the Secretary-General of the Health Science and Technology Committee of the Chinese Geriatric Society, the director of the Chinese Association of Good Health and Good Education, the executive director of the Maternal and Infant Nutrition Committee, and the Supervisor and office director of the Beijing Nutrition Society.


Yang Yu

Professor, Peking University

Yang Yu Peking University Prof. Yang Yu currently serves as the Director of the Clinical Stem Cell Research Center at Peking University Third Hospital and the Deputy Director of the Stem Cell and Regenerative Medicine Center at Peking University. His research focuses on the regulatory mechanisms of female gamete and embryo development, as well as the development of improvement strategies. He has authored or co-authored 73 SCI papers, including publications in prestigious journals such as Cell (2019 & 2020), Nat Commun, Cell Discov, and Nucleic Acids Res. Additionally, he has obtained six granted patents, including international PCT patents.

Weiqi Zhang

Researcher, Beijing Institute of Genomics, Chinese Academy of Sciences (National Bioinformatics Center)

Prof. Weiqi Zhang is affiliated with the National Genomics Data Center at the Beijing Institute of Genomics, Chinese Academy of Sciences. She has been dedicated to the study of aging mechanisms and interventions for an extended period. Her major academic achievements include establishing a new paradigm for studying aging by combining human stem cells with non-human primates. Focusing on multi-organ degeneration, she analyzes the core features and key targets of aging. Using complex data models, she constructs a systemic view of aging and created the first multidimensional aging clock for Chinese women, dissecting the cellular molecular pathways of organism rejuvenation. She proposes the core concept of reshaping cellular aging through epigenetic inheritance and explores new strategies for delaying aging, particularly around natural products and stem cell reprogramming. Prof. Zhang has published over 70 communications or first-authored (including co-authored) papers in prestigious journals such as Cell (3 papers), Nature (2 papers), and Science. She has been interviewed twice by Cell Stem Cell and has contributed invited reviews on aging epigenetic regulation to Nature Reviews Molecular Cell Biology. Prof. Zhang also serves as an Editor for Gerontology Life and Frontiers in Cell and Developmental Biology.


Avi Roy

PhD, Biomedical Science, University of Oxford


Dr. Avi Roy got his Ph.D. in Biomedical Science from the University of Oxford and serves as the Co-Chairman of the Human AI Alignment Project (HAIA) under AI for Human Flourishing. Additionally, he is a Co-founder of DeCancer, a cancer liquid biopsy spinout from the University of Oxford. In his past roles, Avi Roy was a Post-doctoral Research Fellow at the Centre for Sustainable Medical Innovations (CASMI) affiliated with the University of Oxford and University College London. He has demonstrated leadership as the head of the Oxford University Scientific Association and played a pivotal role as a co-founder of Oxford Transhumanism and Emerging Technologies. Avi Roy has contributed to prominent publications like The Guardian and The Conversation.

Bowen Xu

Final year PhD student, Institute of Healthy Ageing, Department of Genetics, Evolution and Environment, University College London

Bowen Xu is a final year PhD student at the Institute of Healthy Ageing, Department of Genetics, Evolution, and Environment at University College London.


Kejun Albert Ying

PhD candidate, Harvard Medical School, Vadim Gladyshev lab

Kejun Albert Ying obtained his BS degree in biology from Sun Yat-sen University in China in 2019.  At the same year,  he started to pursue his PhD degree in Biology at Harvard School of Public Health and Harvard Medical School. He then joined Vadim Gladyshev lab in 2020. His research focuses on understanding the cause of aging and developing ML-based aging biomarkers to facilitate the discovery of novel anti-aging interventions.

bottom of page